ASSOCIATION BETWEEN NEEDLE SIZE, POSTINJECTION REFLUX, AND INTRAOCULAR PRESSURE SPIKES AFTER INTRAVITREAL INJECTIONS
- PMID: 25650712
- DOI: 10.1097/IAE.0000000000000476
ASSOCIATION BETWEEN NEEDLE SIZE, POSTINJECTION REFLUX, AND INTRAOCULAR PRESSURE SPIKES AFTER INTRAVITREAL INJECTIONS
Abstract
Purpose: To compare the effect of 30-gauge versus 32-gauge needle size on postinjection reflux and immediate postinjection intraocular pressure (IOP(immed_post)) spikes in eyes injected with anti-vascular endothelial growth factor agents.
Methods: This was a prospective interventional case series of 65 eyes of 54 consecutive patients in a clinical practice setting who received intravitreal anti-vascular endothelial growth factor therapy. All eyes had preinjection IOP, IOP(immed_post), postinjection reflux, and axial lengths recorded.
Results: There was a higher incidence of postinjection reflux in eyes injected with 30-gauge (53%) compared with those injected with 32-gauge (13%, P = 0.0007). Among 34 eyes injected with 30-gauge, 16 eyes without appreciable postinjection reflux had mean IOP(immed_post) of 44.3 ± 7.48 mmHg and mean IOP(immed_post) elevation of 29.6 ± 2.10 mmHg, which was significantly higher than the 18 eyes with reflux (mean IOP(immed_post) of 18.8 ± 7.15 mmHg and mean IOP(immed_post) elevation of 4.5 ± 1.74 mmHg, P < 0.0001). Among 31 eyes injected with 32-gauge, 27 eyes without appreciable postinjection reflux had mean IOP(immed_post) of 44.4 ± 10.82 mmHg and mean IOP(immed_post) elevation of 29.5 ± 1.99 mmHg, which was significantly higher than the 4 eyes with reflux (mean IOP(immed_post) of 21.3 ± 8.54 mmHg and mean IOP(immed_post) elevation of 9.5 ± 4.05 mmHg, P < 0.001). The differences in reflux and IOP between the two groups were unrelated to axial lengths (P = 0.451).
Conclusion: Eyes receiving injections with 32-gauge needles had a lower incidence of postinjection reflux and higher mean IOP immediately after injection.
Similar articles
-
Intraocular Pressure in Patients with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Aflibercept or Ranibizumab.Ophthalmology. 2015 Sep;122(9):1802-10. doi: 10.1016/j.ophtha.2015.04.018. Epub 2015 May 27. Ophthalmology. 2015. PMID: 26025097 Clinical Trial.
-
The Real-World Effect of Intravitreous Anti-Vascular Endothelial Growth Factor Drugs on Intraocular Pressure: An Analysis Using the IRIS Registry.Ophthalmology. 2018 May;125(5):676-682. doi: 10.1016/j.ophtha.2017.11.027. Epub 2018 Jan 11. Ophthalmology. 2018. PMID: 29336897
-
Hypotensive efficacy of topical brimonidine for intraocular pressure spikes following intravitreal injections of antivascular endothelial growth factor agents: a randomised crossover trial.Br J Ophthalmol. 2019 Oct;103(10):1388-1394. doi: 10.1136/bjophthalmol-2018-312603. Epub 2018 Dec 20. Br J Ophthalmol. 2019. PMID: 30573499 Clinical Trial.
-
Ocular Hypertension Following Intravitreal Antivascular Endothelial Growth Factor Therapy: Review of the Literature and Possible Role of Nitric Oxide.J Glaucoma. 2016 Mar;25(3):291-300. doi: 10.1097/IJG.0000000000000173. J Glaucoma. 2016. PMID: 25318578 Review.
-
Management of immediate and sustained intraocular pressure rise associated with intravitreal antivascular endothelial growth factor injection therapy.Curr Opin Ophthalmol. 2012 Mar;23(2):105-10. doi: 10.1097/ICU.0b013e32834ff41d. Curr Opin Ophthalmol. 2012. PMID: 22249237 Review.
Cited by
-
New prefilled syringe aflibercept design. A cause of symptomatic IOP spike after aflibercept PFS?Rom J Ophthalmol. 2024 Jul-Sep;68(3):219-224. doi: 10.22336/rjo.2024.41. Rom J Ophthalmol. 2024. PMID: 39464766 Free PMC article.
-
Reflux, Intraocular Pressure Variation and Pain Following Intravitreal Ranibizumab Injections Using 30-Gauge or 32-Gauge Needles for Patients With Retinal Pathologies: A Randomized Clinical Trial.Cureus. 2021 Apr 6;13(4):e14320. doi: 10.7759/cureus.14320. Cureus. 2021. PMID: 33968530 Free PMC article.
-
Effect of Estimated Individual Vitreous Volume on Intraocular Pressure Spikes after Intravitreal Anti-Vascular Endothelial Growth Factors Injection.Ophthalmic Res. 2025;68(1):108-116. doi: 10.1159/000543071. Epub 2024 Dec 18. Ophthalmic Res. 2025. PMID: 39694020 Free PMC article.
-
Outcomes of and Surgical Technique for Treatment With High-Dose Aflibercept.J Vitreoretin Dis. 2025 Jul 8:24741264251352890. doi: 10.1177/24741264251352890. Online ahead of print. J Vitreoretin Dis. 2025. PMID: 40656517 Free PMC article.
-
Pain related to intravitreal injections for age-related macular degeneration: a qualitative study of the perspectives of patients and practitioners.BMJ Open. 2023 Aug 16;13(8):e069625. doi: 10.1136/bmjopen-2022-069625. BMJ Open. 2023. PMID: 37586867 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical